| Title : Linagliptin, a DPP-4 inhibitor, ameliorates Abeta (1-42) peptides induced neurodegeneration and brain insulin resistance (BIR) via insulin receptor substrate-1 (IRS-1) in rat model of Alzheimer's disease - Siddiqui_2021_Neuropharmacol__108662 |
| Author(s) : Siddiqui N , Ali J , Parvez S , Zameer S , Najmi AK , Akhtar M |
| Ref : Neuropharmacology , :108662 , 2021 |
| Abstract : Siddiqui_2021_Neuropharmacol__108662 |
| ESTHER : Siddiqui_2021_Neuropharmacol__108662 |
| PubMedSearch : Siddiqui_2021_Neuropharmacol__108662 |
| PubMedID: 34119519 |
Siddiqui N, Ali J, Parvez S, Zameer S, Najmi AK, Akhtar M (2021)
Linagliptin, a DPP-4 inhibitor, ameliorates Abeta (1-42) peptides induced neurodegeneration and brain insulin resistance (BIR) via insulin receptor substrate-1 (IRS-1) in rat model of Alzheimer's disease
Neuropharmacology
:108662
Siddiqui N, Ali J, Parvez S, Zameer S, Najmi AK, Akhtar M (2021)
Neuropharmacology
:108662